Mobile

A randomized, multi-center, placebo controlled 24 week study to compare the efficacy and safety of formoterol Certihaler™ 10µg b.i.d., tiotropium HandiHaler® 18µg o.d. and tiotropium HandiHaler® 18µg...

Update Il y a 4 ans
Reference: EUCTR2004-002089-39

A randomized, multi-center, placebo controlled 24 week study to compare the efficacy and safety of formoterol Certihaler™ 10µg b.i.d., tiotropium HandiHaler® 18µg o.d. and tiotropium HandiHaler® 18µg o.d. in combination with formoterol Certihaler™ 10µg b.i.d. in patients with stable Chronic Obstructive Pulmonary Disease

Woman and Man

  • | Country :
    • -
  • | organs :
    • -
  • | Specialty :
    • -

Extract

To demonstrate that the efficacy of Foradil Certihaler 10μg b.i.d. is superior to placebo following 24 weeks treatment

Inclusion criteria

  • Stable chronic obstructive pulmonary disease

Links